Molecular Biomarkers for Spinal Muscular Atrophy
A Systematic Review
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received November 19, 2019
- Accepted March 5, 2020
- First Published May 29, 2020.
Article Versions
- Previous version (May 29, 2020 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Angela Navarrete-Opazo, MD, PhD,
- Sheldon Garrison, PhD and
- Mindy Waite, PhD
- Angela Navarrete-Opazo, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sheldon Garrison, PhD and
NONE
NONE
NONE
(1) Editorial Board Member, Technology Transfer and Entrepreneurship, 2018- present.
NONE
NONE
(1) Advocate Aurora Health - Aurora Research Institute, Research Scientist, 2017-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Advocate Aurora Health Foundation (no grant number - internal) (2) Ed Howe Center for Health Care Transformation
NONE
NONE
NONE
NONE
NONE
NONE
- Mindy Waite, PhD
NONE
NONE
NONE
NONE
NONE
NONE
(1) Advocate Aurora Health, research scientist, 5 years, (2) University of Wisconsin - Milwaukee, associate lecturer, 2.5 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence
Dr. Navarrete-Opazo angela.navarreteopazo{at}aurora.org
Article usage
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALSJ. H. Veldink, S. Kalmijn, A. H. Van der Hout et al.Neurology, August 10, 2005 -
Article
Intragenic variants in the SMN1 gene determine the clinical phenotype in 5q spinal muscular atrophyRodrigo de Holanda Mendonça, Ciro Matsui, Jr, Graziela Jorge Polido et al.Neurology: Genetics, September 01, 2020 -
Article
Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophyIvon Cuscó, Sara Bernal, Laura Blasco-Pérez et al.Neurology: Genetics, November 11, 2020 -
Articles
SMN1 gene, but not SMN2, is a risk factor for sporadic ALSP. Corcia, W. Camu, J. -M. Halimi et al.Neurology, August 23, 2006